FDA panel rejects MDMA-based treatment for PTSDByNick RobertsonOnJune 4, 2024InPolitics This post was originally published on The Hill Share your love Previous Post Montana's GOP governor fends off challenge from the right, wins primary race Next Post Former Navy SEAL Ryan Zinke wins GOP Montana primary